Study Finds Low Aspirin Uptake for Colorectal Cancer Prevention in Lynch Syndrome Patients

A new study published in The Lancet Gastroenterology & Hepatology indicates that fewer than 10% of individuals with Lynch syndrome are using aspirin to prevent colorectal cancer. Lynch syndrome significantly elevates the risk of this cancer. The findings highlight a notable gap between scientific evidence supporting aspirin's protective effects and its actual application in patient care, suggesting a need for improved implementation strategies.